Quantcast
Last updated on April 18, 2014 at 6:30 EDT

Latest Clinical trial Stories

2014-03-25 16:25:46

Panel Will Provide Expertise on Trial Selection, Design and Implementation WASHINGTON, March 25, 2014 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today appointed 10 people as members of PCORI's new Advisory Panel on Clinical Trials. It is one of two new advisory panels whose members the Board approved at its meeting today; the other focuses on rare disease. Members of the Advisory Panel on Clinical Trials will support...

2014-03-24 12:30:14

MUMBAI, March 24, 2014 /PRNewswire/ -- Bharat Book Bureau presents Chinese guidebook for Adverse Drug Reaction Reporting and Monitoring Regulations. China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world. Along with sustained economic and population growth, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. By 2013, total value of drugs...

2014-03-21 08:25:00

Leveraging Proprietary Mucoadhesive Polymer Hydrogel Technology to Expand Product Offerings; Seeking Global Marketing Partners NEW YORK, March 21, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced that it has advanced development of a new proprietary product, called ProctiGard(TM), for the treatment of radiation proctitis. Radiation proctitis ("RP") is a significant unmet medical need, with no well-established standard of care. It is estimated that there are...

2014-03-21 08:24:29

DUBLIN, Mar. 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/4m4gr3/medical_device ) has announced the addition of the "Medical Device Clinical Studies - Understand How to Conduct Pre and Post Market Medical Device Clinical Studies (Course, London)" conference to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The Medical Device Clinical Studies Course will take place on the 1st & 2nd April 2014 at the...

2014-03-20 16:26:39

Quizartinib Phase 3 Trial Expected to Begin in Second Quarter 2014 SAN DIEGO, March 20, 2014 /PRNewswire/ -- Ambit Biosciences (NASDAQ: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced fourth quarter and full-year operating results for 2013. The company will host a conference call today to discuss financial results for the fourth quarter and full-year 2013, and to...

2014-03-20 12:32:57

RALEIGH, N.C., March 20, 2014 /PRNewswire/ -- Clintrax Global, Inc., a worldwide clinical trial contract negotiation company located in Raleigh, NC, recently announced the addition of global investigator payments to its list of client services. Investigator payments are an essential part of the clinical trial lifecycle in which the site and other responsible contracting parties are compensated for services rendered and work performed throughout the course of a particular study....

2014-03-20 12:29:25

LONDON, March 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Liver Fibrosis Global Clinical Trials Review, H2, 2013 Liver Fibrosis Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, "Liver Fibrosis Global Clinical Trials Review, H2, 2013" provides data on the Liver Fibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Fibrosis. It includes an...

2014-03-20 12:29:18

LONDON, March 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2013 Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, "Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2013" provides data on the Post-Traumatic Stress Disorder (PTSD) clinical trial scenario. This report provides...

2014-03-20 08:30:21

Locating Investigational Sites Has Never Been Easy. COSTA MESA, Calif., March 20, 2014 /PRNewswire-iReach/ -- WCCT Global, a full service CRO specializing in early and late phase clinical research announced today the implementation of a cutting edge technology that allows WCCT Global to assist sponsors in identifying clinical investigational sites (CIS) that would be the best fit for their upcoming clinical trial anywhere in the United States. Clinical Investigational Sites are...

2014-03-19 23:24:32

General Genetics Corporation (GGC) announces a new pharmacogenomic testing study that investigates the frequency of adverse drug effects on a select population with known genetic variations that affect drug metabolic pathways, to determine if pharmacogenomic testing can ameliorate risks. Las Cruces, New Mexico (PRWEB) March 19, 2014 General Genetics Corporation (GGC) announced today an investigative study of pharmacogenomic testing (PGx) value when managing criteria-specific patients who...